A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Articles|August 3, 2011
Contraception - Lactational Amenorrhea Method
Author(s)M. Nabil El-Tabbakh, MD
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
2
Reactions to FDA's boxed warning removals for menopausal hormone therapy
3
FDA removes boxed warnings from 3 more menopausal hormone therapy products
4
Top video interviews from The Menopause Society 2026 Annual Meeting
5